Activity and substrate specificity of pyrimidine phosphorylases and their role in fluoropyrimidine sensitivity in colon cancer cell lines

This publication has 38 references indexed in Scilit:

• Lack of contribution of dihydrofluorouracil and α-fluoro-β-alanine to the cytotoxicity of 5'-deoxy-5-fluorouridine on human keratinocytes
  Anti-Cancer Drugs, 2004
• Uridine phosophorylase: An important enzyme in pyrimidine metabolism and fluoropyrimidine activation
  Drugs of Today, 2004
• Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity
  British Journal of Cancer, 2003
• Rapid disappearance of deoxyribose-1-phosphate in platelet derived endothelial cell growth factor/thymidine phosphorylase overexpressing cells
  Biochemical and Biophysical Research Communications, 2003
• Structure and activity of specific inhibitors of thymidine phosphorylase to potentiate the function of antitumor 2′-deoxyribonucleosides
  Published by Elsevier ,2000
• Thymidine phosphorylase: its role in sensitivity and resistance to anticancer drugs
  Drug Resistance Updates, 1999
• Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes
  Molecular Carcinogenesis, 1998
• 19F NMR monitoring ofin vivo tumor metabolism after biochemical modulation of 5-fluorouracil by the uridine phosphorylase inhibitor 5-benzylacyclouridine
  Magnetic Resonance in Medicine, 1997
• Immunoreactive dUMP and TTP pools as an index of thymidylate synthase inhibition; effect of tomudex (ZD1694) and a nonpolyglutamated quinazoline antifolate (CB30900) in L1210 mouse leukaemia cells
  Biochemical Pharmacology, 1996
• Platelet‐derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: An immunohistochemical study
  The Journal of Pathology, 1995